Julie E. Bauman

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

Shanthi Marur, Shuli Li, Anthony J. Cmelak et al. · Journal of Clinical Oncology · 2017 · 486 citations · Full text

Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Laurie L. Carr, David A. Mankoff, Bernardo Goulart et al. · Clinical Cancer Research · 2010 · 417 citations · Full text

Drug repurposing from an academic perspective

Tudor I. Oprea, Julie E. Bauman, Cristian Bologa et al. · Drug Discovery Today Therapeutic Strategies · 2011 · 363 citations

Academic Perspective, Substance Abuse, Drug Repositioning +9

Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial

Renato Martins, Upendra Parvathaneni, Julie E. Bauman et al. · Journal of Clinical Oncology · 2013 · 201 citations · Full text

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma

Matthew L. Hedberg, Gerald Goh, Simion I. Chiosea et al. · Journal of Clinical Investigation · 2015 · 199 citations · Full text